Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Office-Based Superior Laryngeal Nerve (SLN) Block for Treatment of Neurogenic Cough

NCT04642352 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT04642352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04642352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Office-Based Superior Laryngeal Nerve (SLN) Block for Treatment of Neurogenic Cough
Lead sponsor
University of Alabama at Birmingham
Phase
Observational
Overall status
Recruiting
Start date
January 3, 2022
Completion date
October 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cough